Eli Lilly

February 22, 2024

Ozempic Gastro Effects

Ozempic Gastro Effects. The weight-loss injectable medications are on track for another bumper growth this year, with some experts predicting that 15 million Americans will be on these types of drugs by 2030. But blockbuster success is not without its price.

Ozempic Gastro Effects can be serious including stomach paralysis, ileus or small intestine blockage, and the need for painful expensive surgery. Injured? Call Dr. Shezad Malik at 214-390-3189

Heavy Advertisement Barrage

Although advertisements tout these drugs as both safe and effective, with few long-term side effects, some patients are now pursuing Ozempic, Wegovy, and Mounjaro lawsuits against the manufacturers, each raising similar allegations that the drug labels fail to adequately warn about the risk of severe and long-lasting side effects, including a form of severe stomach paralysis, known as gastroparesis.

What is Ozempic?

Ozempic (semaglutide) was approved by the FDA, for the treatment of people with Type 2 diabetes, and an interesting side effect was noted, patients lost weight while on the medication.

Since that discovery, with aggressive advertisements promoting the weight loss benefits, Ozempic has been pushed as a miracle diet drug in recent years, making it a blockbuster treatment for weight loss that is now used by millions of Americans.

Since Ozempic for weight loss sales exceeded Novo Nordisk’s expectations, the company then released a higher dose version under the brand name Wegovy, which is specifically approved by the FDA as a diet drug. Continue reading

August 12, 2014

Actos Bladder Cancer Questions and Answers

by Dr. Shezad Malik

There are several thousand lawsuits filed by folks both in state and federal courts by patients who took the prescription drug pioglitazone, sold as brand name Actos and later developed bladder cancer. Doctors prescribe Actos to treat patients with Type 2 Diabetes.

Takeda Actos Bladder Cancer Verdict

On April 7, 2014, a federal jury in Louisiana found Takeda failed to adequately warn about bladder cancer risks of Actos. Jurors also found that executives of Takeda acted with wanton and reckless disregard for patient safety and awarded a total of $9 billion in punitive damages.

August 4, 2014

Takeda Seeks New Trial After Losing Actos Bladder Cancer Trial

by Dr. Shezad Malik

After a record breaking pharmaceutical $9 billion jury verdict involving Actos bladder cancer lawsuit, Takeda Pharmaceuticals and Eli Lilly, Actos manufacturers, have filed for a new trial. Takeda Pharmaceuticals and Eli Lilly, claim that the massive award shows that the jury acted with “passion and prejudice”.

Actos Record $9B Verdict

In April, a federal jury in Louisiana hammered Takeda with $1.5 million in compensatory damages and a whopping $9 billion in punitive damages. Terrance Allen and his wife’s claim, was the first out of several thousand Actos lawsuits in the federal court system to go to trial.

April 9, 2014

Louisiana Jury Hammers Takeda Actos Bladder Cancer $9 Billion Verdict

by Dr. Shezad Malik

The jury in federal court in Louisiana, sent a loud and clear message on Monday, in rendering a bombshell verdict. Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages. The federal court jury found they hid the cancer risks of their Actos diabetes drug in the first federal U.S. trial.

https://www.youtube.com/watch?v=G4ItYan1QWo&feature=player_detailpage

Takeda, Lilly $9 Billion Punitive DamagesTakeda, based in Osaka, Japan, was ordered to pay $6 billion by the jury yesterday in Lafayette, Louisiana. Indianapolis-based Eli Lilly, Takeda’s partner, was ordered to pay $3 billion. Punitive damages are awarded in these types of cases to punish the companies for their wrongful acts.

April 6, 2014

Louisiana Actos Bladder Cancer Trial Verdict Pending

by Dr. Shezad Malik

After 33 grueling days of hotly contested trial testimony, the first federal Actos bladder cancer lawsuit trial has ended. The jury is scheduled to hear closing arguments on Monday and then deliberations will begin.

Federal Actos Trial: The Details

January 21, 2014

Byetta, Januvia Pancreatic Cancer Litigation Update

by Dr. Shezad Malik

In the federal court system, a Multidistrict Litigation (MDL) has been established to centralize Byetta, Januvia, Janumet and Victoza pancreatic cancer lawsuits filed in U.S. District Courts by the users of these diabetic drugs.

There are currently at least 262 cases consolidated as part of an MDL, before U.S. District Judge Battaglia in the Southern District of California. Next discovery and pretrial proceedings will proceed, and bellwether trials will be scheduled, probably some time in 2015.